⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | HDFC Pharma and Healthcare Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - IDCW - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | HDFC MF | HDFC MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹21.95 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | BSE Health Care - TRI | BSE Health Care - TRI |
| Fund Manager | Nikhil Mathur | Nikhil Mathur |
| Inception | 04 Oct 2023 | 04 Oct 2023 |
| Returns | ||
| 1Y | 22.64% | 22.64% |
| 3Y | 30.41% | 30.41% |
| 5Y | — | — |
| Since Inception | 29.15% | 29.15% |
| Risk | ||
| 14.07 | 14.07 | |
| 0.59 | 0.59 | |
| 1.59 | 1.59 | |
| 21.67 | 21.67 | |
| 3.48 | 3.48 | |
| -9.23% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.03% | 1.03% |
| Exit Load | 1% on or before 30D, Nil after 30D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
HDFC MF22%
HDFC MF22%
77.6%Only 77.6% of holdings by weight are common between HDFC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingHDFC MFHDFC MF
Divi's Laboratories Ltd.9.39%9.39%
Sun Pharmaceutical Industries Ltd.8.28%8.28%
TREPS - Tri-party Repo4.67%4.67%
Alkem Laboratories Ltd.4.64%4.64%
Cipla Ltd.4.15%4.15%
Apollo Hospitals Enterprise Ltd.3.69%3.69%
Torrent Pharmaceuticals Ltd.3.65%3.65%
Max Healthcare Institute Ltd.3.61%3.61%
Aster DM Quality Care Ltd.3.56%3.56%
Lupin Ltd.3.55%3.55%
Neuland Laboratories Ltd.3.24%3.24%
Shilpa Medicare Ltd.3.23%3.23%
Dr. Reddy's Laboratories Ltd.3.19%3.19%
Acutaas Chemicals Ltd.3.18%3.18%
Anthem Biosciences Ltd.3.17%3.17%
Ipca Laboratories Ltd.2.98%2.98%
Global Health Ltd.2.72%2.72%
Rubicon Research Ltd.2.52%2.52%
Krishna Institute of Medical Sciences Ltd2.10%2.10%
Glenmark Pharmaceuticals Ltd.2.09%2.09%
Category context: Equity vs Equity. Open the full Screener →